ZTS | Zoetis
161.49 -5.00 (-3.00%)
ZTS Price Profile
$164.12
$161.49
161.42 - 165.18
156.67 - 249.27
89.82B
1.61M
166.49
223.36
473.13M
472.41M
2.84M
0.66
3.27
2.02M
0.43%
1.35
24.74%
4.15
0.11
3.14B
4.64B
3.3B
6.76B
- MRQ = Most Recent Quarter.
- TTM = Trailing Twelve Months.
Zoetis (ZTS) company profile
Zoetis Inc. (NYSE: ZTS) is an American company that discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products with customers globally. The company also offers pharmaceutical products, including pain and sedation, antiemetic, reproductive, and oncology products. The company’s business focuses on commercializing products across eight key species: dogs, cats, horses, cattle, swine, poultry, fish, and sheep.